Effect of dapagliflozin on colon cancer cell

Endocrine Journal

Volumn 62, Issue 12, 2015, Pages 1133-1137

  Saito, Tsugumichi ^a   Okada, Shuichi ^a   Yamada, Eijiro ^a   Shimoda, Yoko ^a   Osaki, Aya ^a   Tagaya, Yuko ^a   Shibusawa, Ryo ^a   Okada, Junichi ^a   Yamada, Masanobu ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colon cancer; Diabetes mellitus; SGLT2 inhibitor

Indexed keywords

CASPASE 3; DAPAGLIFLOZIN; GLUCURONOSYLTRANSFERASE 1A9; MITOGEN ACTIVATED PROTEIN KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHLORIZIN; 2-(3-(4-ETHOXYBENZYL)-4-CHLOROPHENYL)-6-HYDROXYMETHYLTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL; ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; BENZHYDRYL DERIVATIVE; GLUCOSIDE; GLUCURONOSYLTRANSFERASE; SLC5A2 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 2; UDP-GLUCURONOSYLTRANSFERASE 1A9;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL COUNT; CELL DEATH; CELL POPULATION; CELL VIABILITY; COLON CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG METABOLISM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; ANTAGONISTS AND INHIBITORS; COLON TUMOR; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; HCT 116 CELL LINE; HUMAN; METABOLISM; PATHOLOGY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BENZHYDRYL COMPOUNDS; CELL COUNT; COLONIC NEOPLASMS; DIABETES MELLITUS, TYPE 2; GLUCOSIDES; GLUCURONOSYLTRANSFERASE; HCT116 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; SODIUM-GLUCOSE TRANSPORTER 2;

EID: 84952011242     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ15-0396     Document Type: Article

References (9)

1. Vivian EM (2015) Dapagliflozin: a new sodium-glu- cose cotransporter 2 inhibitor for treatment of type 2 diabetes. Am J Health Syst Pharm 72: 361-372.
2. Zhao FQ, McFadden TB, Wall EH, Dong B, Zheng YC (2005) Cloning and expression of bovine sodium/glucose cotransporter SGLT2. J Dairy Sci 88: 2738-2748.
3. Kasichayanula S, Liu X, Pe Benito M, Yao M, Pfister M, et al. (2013) The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus. Br J Clin Pharmacol 76: 432-444.
4. Liu M, Wang Q, Liu F, Cheng X, Wu X, et al. (2013) UDP-glucuronosyltransferase 1A compromises intracellular accumulation and anti-cancer effect of tanshinone IIA in human colon cancer cells. PLoS One 8: e79172.
5. Szablewski L (2013) Expression of glucose transporters in cancers. Biochim Biophys Acta 1835: 164-169.
6. Tagaya Y, Miura A, Okada S, Ohshima K, Mori M (2012) Nucleobindin-2 Is a Positive Modulator of EGF- Dependent Signals Leading to Enhancement of Cell Growth and Suppression of Adipocyte Differentiation. Endocrinology. 153: 3308-3319.
7. Yamaguchi K, Kato M, Suzuki M, Asanuma K, Aso Y, et al. (2011) Pharmacokinetic and pharmacodynamic modeling of the efffect of a sodium-glucose cotransporter inhibitor, phlorizin, on renal glucose transport in rats. DrugMetab Dispos 39: 1801-1807.
8. Kao AW, Waters SB, Okada S, Pessin JE (1997) Insulin Stimulates the Phosphorylation of the 66- and 52-Kilodalton Shc Isoforms by Distinct Pathways. Endocrinology 138: 2474-2480.
9. Dou, X, Wilkemeyer MF, Menkari CE, Parnell SE, Sulik KK, et al. (2013) Mitogen-activated protein kinase modulates ethanol inhibition of cell adhesion mediated by the L1 neural cell adhesion molecule. Proc Natl Acad Sci U S A. 2013 110: 5683-5688.